Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin

Issa F. Khouri, Cindy Ippoliti, James Gajewski, Donna Przepiorka, Richard E. Champlin

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Cytopenias following bone marrow transplantation may be severe and life-threatening. These have been described post-allogeneic Klumpp, 1991: Bone Marrow Transplant 8:159-171. or post-autologous bone marrow transplants Khouri et al., 1994: J Clin Oncol 12:749-758. as well as with peripheral blood stem cell transplantation Klumpp et al., 1992: Am J Hematol 41:215- 217. It can be immune mediated, associated on occasions with graft-versus- host disease (GVHD) Anasetti et al., 1989: Blood 4:1054-1058; however, in most cases, the underlying mechanism is uncertain. The treatment of post- transplant cytopenias is not well established, and they are often refractory to immunosuppressive therapy with steroids. Herein we describe two cases of neutropenia after allogeneic bone marrow transplantation that improved after therapy with high-dose intravenous immunoglobulin.

Original languageEnglish (US)
Pages (from-to)313-315
Number of pages3
JournalAmerican Journal of Hematology
Volume52
Issue number4
DOIs
StatePublished - 1996

Keywords

  • neutropenias
  • post ABMT and IVIG

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin'. Together they form a unique fingerprint.

Cite this